Aubrey Reynolds | executive |
Scott Wagner | executive |
Karsten Voermann | executive |
Stephanie Davis | analyst |
Charles Rhyee | analyst |
Lisa Gill | analyst |
Scott Schoenhaus | analyst |
Stanislav Berenshteyn | analyst |
Sean Dodge | analyst |
Jailendra Singh | analyst |
Allen Lutz | analyst |
Daniel Grosslight | analyst |
George Hill | analyst |
Eric Sheridan | analyst |
Daniel Christopher Clark | analyst |
Hello, ladies and gentlemen, and thank you for standing by, and welcome to the GoodRx Third Quarter 2024 Earnings Call.
As a reminder, today's conference call is being recorded. I would now like to introduce your host for today's call, Aubrey Reynolds, Director of Investor Relations. Ms. Reynolds, you may begin.
Thank you, operator.